Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

Author:

Rischard Franz P.1ORCID,Bernardo Roberto J.2ORCID,Vanderpool Rebecca R.3ORCID,Kwon Deborah H.4ORCID,Acharya Tushar5,Park Margaret M.4ORCID,Katrynuik Austin6,Insel Michael1,Kubba Saad5,Badagliacca Roberto7ORCID,Larive A. Brett8,Naeije Robert9,Garcia Joe G.N.6ORCID,Beck Gerald J.8,Erzurum Serpil C.10,Frantz Robert P.11ORCID,Hassoun Paul M.12,Hemnes Anna R.13ORCID,Hill Nicholas S.14ORCID,Horn Evelyn M.15ORCID,Leopold Jane A.16ORCID,Rosenzweig Erika B.17ORCID,Tang W.H. Wilson4ORCID,Wilcox Jennifer D.18ORCID

Affiliation:

1. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine (F.P.R., M.I.), University of Arizona, Tuscon.

2. Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City (R.J.B.).

3. Division of Cardiovascular Medicine, The Ohio State University, Columbus (R.R.V.).

4. Department of Cardiovascular Medicine (D.H.K., M.M.P., W.H.W.T.), Cleveland Clinic, Cleveland, OH.

5. Divison of Cardiology (T.A., S.K.), University of Arizona, Tuscon.

6. Department of Medicine (A.K., J.G.N.G.), University of Arizona, Tuscon.

7. Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Italy (R.B.).

8. Department of Quantitative Health Sciences (A.B.L., G.J.B.), Cleveland Clinic, Cleveland, OH.

9. Department of Pathophysiology, Free University of Brussels, Belgium (R.N.).

10. Lerner Research Institute (S.C.E.), Cleveland Clinic, Cleveland, OH.

11. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (R.P.F.).

12. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD (P.M.H.).

13. Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN (A.R.H.).

14. Division of Pulmonary, Critical Care, and Sleep Medicine, Tufts Medical Center, Boston, MA (N.S.H.).

15. Division of Cardiology, Perkin Heart Failure Center, Weill Cornell Medicine, New York, NY (E.M.H.).

16. Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (J.A.L.).

17. Department of Pediatrics and Medicine, Columbia University, Vegelos College of Physicians and Surgeons, New York, NY (E.B.R.).

18. Department of Cardiovascular and Metabolic Sciences (J.D.W.), Cleveland Clinic, Cleveland, OH.

Abstract

Background: Normative changes in right ventricular (RV) structure and function have not been characterized in the context of treatment-associated functional recovery (RV functional recovery [RVFnRec]). The aim of this study is to assess the clinical relevance of a proposed RVFnRec definition. Methods: We evaluated 63 incident patients with pulmonary arterial hypertension by right heart catheterization and cardiac magnetic resonance imaging at diagnosis and cardiac magnetic resonance imaging and invasive cardiopulmonary exercise testing following treatment (≈11 months). Sex, age, ethnicity matched healthy control subjects (n=62) with 1-time cardiac magnetic resonance imaging and noninvasive cardiopulmonary exercise testing were recruited from the PVDOMICS (Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics) project. We examined therapeutic cardiac magnetic resonance imaging changes relative to the evidence-based peak oxygen consumption (VO 2peak )>15 mL/(kg·min) to define RVFnRec by receiver operating curve analysis. Afterload was measured as mean pulmonary artery pressure, resistance, compliance, and elastance. Results: A drop in RV end-diastolic volume of −15 mL best defined RVFnRec (area under the curve, 0.87; P =0.0001) and neared upper 95% CI RV end-diastolic volume of controls. This cutoff was met by 22 out of 63 (35%) patients which was reinforced by freedom from clinical worsening, RVFnRec 1 out of 21 (5%) versus no RVFnRec 17 out of 42, 40% (log-rank P =0.006). A therapy-associated increase of 0.8 mL/mm Hg in compliance had the best predictive value of RVFnRec (area under the curve, 0.76; [95% CI, 0.64–0.88]; P =0.001). RVFnRec patients had greater increases in stroke volume, and cardiac output at exercise. Conclusions: RVFnRec defined by RV end-diastolic volume therapeutic decrease of −15 mL predicts exercise capacity, freedom from clinical worsening, and nears normalization. A therapeutic improvement of compliance is superior to other measures of afterload in predicting RVFnRec. RVFnRec is also associated with increased RV output reserve at exercise.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3